Wednesday, November 11, 2026
22.6 C
Bengaluru

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial strategy, supply chain management, procurement, operations, and sustainability, Rajesh brings a strong track record of driving transformation and growth across global markets.

Before joining ACG, Rajesh held several leadership positions at EPL Ltd. (Essel Propack Ltd.), where he led global supply chain and sustainability initiatives across multiple countries. His career also includes significant leadership experience at BASF India and Asian Paints, where he contributed to large-scale initiatives spanning supply chain transformation, strategic procurement, operational excellence, digitalisation, inventory optimisation, and cost transformation.

In his new role as Chief Commercial Officer, Rajesh will lead ACG’s global commercial strategy, strengthen strategic partnerships, support market expansion, and drive initiatives focused on commercial excellence and sustainable growth.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img